Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Japan Ethical Drug Market Contracts 1% in Jan.-Mar.; Keytruda Top-Selling Drug for 8th Quarter Running: IQVIA
May 25, 2021
- Janssen Seeks Japan Approval for COVID-19 Vaccine
May 24, 2021
- Takeda’s CMV Drug Maribavir Gets FDA’s Priority Review
May 24, 2021
- Chugai’s FoundationOne Liquid Grabs Nod as Lynparza CDx
May 24, 2021
- AbbVie Looks to Continue Double-Digit Annual Growth in New 5-Year Biz Plan
May 21, 2021
- Novo CEO Eyes 6-10% Annual Growth, Voices Hope for Rybelsus Tie-Up in Japan
May 20, 2021
- Third GPCR-Targeted Drug Enters Clinic under Sosei/Pfizer Collaboration
May 20, 2021
- Medicago’s COVID-19 Vaccine Yields Positive Interim Data: PII
May 20, 2021
- Life Science Institute to Establish New Field of Reparative Medicine with Muse Cells: President
May 20, 2021
- Janssen’s Darzquro, Chugai’s Polivy, JCR’s Izcargo Now Available in Japan
May 20, 2021
- Meiji Holdings Aims for 209 Billion Yen Pharma Sales in FY2023: New Biz Plan
May 20, 2021
- Nichi-Iko Chief to Take 50% Pay Cuts until Business Recovery
May 20, 2021
- 5-Camp Battle Heating Up in HIF-PH Market; Evrenzo, Duvroq Neck-and-Neck for Top Spot
May 19, 2021
- Fujifilm, BlueRock Form Strategic Alliance to Develop iPSC Therapies for Ocular Diseases
May 19, 2021
- Tord Labuda Becomes Interim Chief of LEO Pharma Japan, Sakurai Resigns
May 19, 2021
- Reps’ Face-to-Face Meetings for GPs Back to Prepandemic Levels in March: Intage
May 19, 2021
- Nichi-Iko Refrains from June Listing to Focus on Re-Supply of Existing Drugs
May 18, 2021
- Nipro Pharma to Build New Injectable Plant in Shiga
May 18, 2021
- Takeda, Fujitsu, NCC Join Forces to Analyze Journey of Ovarian Cancer Patients
May 18, 2021
- Big 4 Wholesalers’ Operating Margin Sinks to 0.49% on COVID-19, Competition
May 17, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…